them_PRP are_VBP related_JJ to_TO medical_JJ outcomes_NNS and_CC are_VBP publicly_RB available_JJ ._.
A_DT substantial_JJ amount_NN of_IN data_NNS is_VBZ censored_VBN and_CC also_RB missing_VBG ._.
The_DT SUPPORT_NNP data_NNS set_NN is_VBZ a_DT random_JJ sample_NN from_IN Phases_NNS I_CD and_CC II_CD of_IN the_DT SUPPORT_NN =_JJ -_: =[_NN 9_CD -RRB-_-RRB- -_: =_JJ -_: -LRB-_-LRB- Study_NNP to_TO Understand_NNP Prognoses_NNP Preferences_NNPS Outcomes_NNPS and_CC Risks_NNS of_IN Treatment_NNP -RRB-_-RRB- study_NN ._.
As_IN suggested_VBN in_IN -LRB-_-LRB- 7_CD -RRB-_-RRB- we_PRP split_VBD the_DT data_NNS set_VBN into_IN four_CD different_JJ subsets_NNS ,_, each_DT corresponding_VBG to_TO a_DT different_JJ cause_NN of_IN de_FW
